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Abstract  
Diffuse large B-cell lymphomas (DLBCLs) are markedly heterogeneous,
 
and there is increasing 
evidence that the biological features
 
of these tumors vary according to the primary site of disease
 
(lymph node or various extranodal organs). The Waldeyer’s ring (WR), a circular band of mucosa-
associated lymphoid tissue
 
composed of the palatine, lingual and pharyngeal tonsils, is
 
the second most 
common site of extranodal invovlement by DLBCL.
 
The presence of focal follicular features in 
tonsillar DLBCLs
 
has been previously reported. In this study we included 209
 
adult patients with de 
novo DLBCL presenting in the WR consecutively
 
included in the GELA protocols during a 10-year 
period (1993–2004). All patients (M/F ratio: 1,77/1, mean age 59 years) comprising 81% with stages I–
II and 19% with stages III–IV disease, received intent-to-cure anthracyclin-based polychemotherapy. 
Morphology, pattern of growth, immunophenotype and differentiation
 
profile were analyzed and 
correlated to the clinical features.
 
Survival and outcome were analyzed in comparison to a matched
 
cohort of patients with primary nodal DLBCL. By morphology,
 
55% of tonsillar cases were classified 
as centroblastic, 39%
 
as centroblastic-polymorphous, 3% as immunoblastic, and 3% were
 
unclassifiable. Among large biopsy specimens (n=79), 18% had
 
a prominent nodular pattern consistent 
with transformed follicular
 
lymphomas, 35% had a minor nodular component (<50%) interpreted
 
as 
follicular colonization and 47% were purely diffuse. The
 
nodular pattern correlated with centroblastic 
morphology (p=0,0007).
 
The prevalence of antigen expression was: bcl-2: 105/189 (60%);
 
CD10: 
75/178 (42%); bcl-6 :40/76 (53%); mum-1:40/109 (37%).
 
Global immunophenotypic profile assessed 
on 136 cases was GC-like
 
in 60% and non-GC-like in 40%. The GC-like profile correlated
 
with 
absence of bcl-2 expression (p<0,0001) and with centroblastic
 
morphology (p=0,04). In multivariate 
analysis, the GC-like phenotype
 
correlated with better OS (p=0.014), and CD10 expression correlated
 
with better EFS (p=0.0061). For 144 paired tonsillar/nodal cases,
 
the complete remission rate was 
significantly better for tonsillar
 
patients (p=0.01) but the 5-y OS and EFS rates - respectively,
 
79,7% 
and 70,9% for tonsillar patients, and 76,7% and 66,7%
 
for nodal patients - did not significantly differ. 
When restriciting
 
the comparison to the cases with no factor of the age-adjusted
 
IPI (109 paired 
patients), the primary tonsillar localization
 
was associated with a higher 5-y EFS (78,5% vs. 71,2%; 
p=0,029)
 
and 0S (84,7% vs. 79,8%; p=0,047) rates. In conclusion, WR DLBCLs
 
frequently have a 
partially follicular pattern of growth, and
 
a GC-like phenotype. In DLBCL patients with no factor of 
the
 
age-adjusted IPI, the tonsillar localization appears to confer
 
a better outcome than primary nodal 
involvement.
 
 
 
